Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9769)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2014 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vespasiani-Gentilucci U, Gallo P, Vincentis AD, Galati G, Picardi A. Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis. World J Gastroenterol 2014; 20(11): 2825-2838 [PMID: 24659875 DOI: 10.3748/wjg.v20.i11.2825] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i11/2825.htm |
| Number | Citing Articles |
| 1 |
Hung-Yu Sun, Pin-Nan Cheng, Chiung-Ying Tseng, Wei-Jen Tsai, Yen-Cheng Chiu, Kung-Chia Young. Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection. Gut 2018; 67(7): 1342 doi: 10.1136/gutjnl-2017-313832
|
| 2 |
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infection. World Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
|
| 3 |
Umberto Vespasiani-Gentilucci, Chiara Dell’Unto, Antonio De Vincentis, Andrea Baiocchini, Marco Delle Monache, Roberto Cecere, Adriano Maria Pellicelli, Valerio Giannelli, Simone Carotti, Giovanni Galati, Paolo Gallo, Francesco Valentini, Franca Del Nonno, Davide Rosati, Sergio Morini, Raffaele Antonelli-Incalzi, Antonio Picardi. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/7564835
|
| 4 |
Abdel Hady A. Abdel Wahab, Medhat S. El-Halawany, Ahmad A. Emam, Ammar Elfiky, Zakaria Y. Abd Elmageed. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus. Biomarkers 2016; : 1 doi: 10.1080/1354750X.2016.1252966
|
| 5 |
Hui Cao, Xiaosong Chen, Zhijun Wang, Lei Wang, Qiang Xia, Wei Zhang. The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation. Cell Death Discovery 2020; 6(1) doi: 10.1038/s41420-020-0287-y
|
| 6 |
Daniel Pineda-Tenor, Juan Berenguer, María A. Jiménez-Sousa, Ana Carrero, Mónica García-Álvarez, Teresa Aldámiz-Echevarria, Pilar García-Broncano, Cristina Diez, María Guzmán-Fulgencio, Amanda Fernández-Rodríguez, Salvador Resino. rs7903146 Polymorphism atTranscription Factor 7 Like 2Gene Is Associated with Total Cholesterol and Lipoprotein Profile in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Research and Human Retroviruses 2015; 31(3): 326 doi: 10.1089/aid.2014.0195
|
| 7 |
Allison Cázares-Cortazar, Luis A. Uribe-Noguez, José Antonio Mata-Marín, Jesús Gaytán-Martínez, María de la Luz Martínez-Rodríguez, Pedro Esteban Villavicencio-Ferrel, Alberto Chapararro-Sánchez, Stefan Mauss, Alicia Ocaña-Mondragón. A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress. Archives of Virology 2020; 165(12): 2759 doi: 10.1007/s00705-020-04797-y
|
| 8 |
Sakthi Priya Selvamani, Anis Khan, Enoch S E Tay, Matthew Garvey, Harout Ajoyan, Eve Diefenbach, Brian S Gloss, Thomas Tu, Jacob George, Mark W Douglas. Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis. The Journal of Infectious Diseases 2024; 230(5): e1012 doi: 10.1093/infdis/jiae210
|
| 9 |
Beti Todorovska, Nenad Joksimovic, Viktorija Caloska-Ivanova, Magdalena Dimitrova-Genadieva, Meri Trajkovska, Elena Curakova, Sanja Kiprijanovska, Beti Zafirova-Ivanovska, Vladimir Serafimoski. Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin. PRILOZI 2017; 38(1): 25 doi: 10.1515/prilozi-2017-0003
|
| 10 |
Silvia Goñi Esarte, Regina Juanbeltz, José Manuel Zozaya, Juan Isidro Úriz, Jesús Castilla, José Ignacio Herrero. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents. Gastroenterología y Hepatología 2020; 43(5): 248 doi: 10.1016/j.gastrohep.2019.03.017
|
| 11 |
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk Moussa. Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD). Arab Journal of Gastroenterology 2019; 20(1): 61 doi: 10.1016/j.ajg.2019.02.002
|
| 12 |
Seng Gee Lim, Alessio Aghemo, Pei-Jer Chen, Yock Young Dan, Edward Gane, Rino Gani, Robert G Gish, Richard Guan, Ji Dong Jia, Kieron Lim, Teerha Piratvisuth, Samir Shah, Mitchell L Shiffman, Frank Tacke, Soek Siam Tan, Tawesak Tanwandee, Khin Maung Win, Cihan Yurdaydin. Management of hepatitis C virus infection in the Asia-Pacific region: an update. The Lancet Gastroenterology & Hepatology 2017; 2(1): 52 doi: 10.1016/S2468-1253(16)30080-2
|
| 13 |
Ming-Ling Chang, Yu-sheng Lin, Li-Heng Pao, Hsin-Chih Huang, Cheng-Tang Chiu. Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearance. Scientific Reports 2017; 7(1) doi: 10.1038/srep42503
|
| 14 |
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner. Biomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
|
| 15 |
Umberto Vespasiani-Gentilucci, Giovanni Galati, Paolo Gallo, Antonio De Vincentis, Elisabetta Riva, Antonio Picardi. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens. World Journal of Gastroenterology 2015; 21(24): 7412-7426 doi: 10.3748/wjg.v21.i24.7412
|
| 16 |
Javier Ampuero, Manuel Romero-Gómez. Assessing cardiovascular risk in hepatitis C: An unmet need. World Journal of Hepatology 2015; 7(19): 2214-2219 doi: 10.4254/wjh.v7.i19.2214
|
| 17 |
Qi-tao Huang, Li-lin Hang, Mei Zhong, Yun-fei Gao, Man-ling Luo, Yan-hong Yu. Maternal HCV infection is associated with intrauterine fetal growth disturbance. Medicine 2016; 95(35): e4777 doi: 10.1097/MD.0000000000004777
|
| 18 |
Mubeen Khan Mohammed Abdul, Heather S. Snyder, Mythili Chunduru, Susan M.K. Lee, Sanjaya K. Satapathy. Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure. Current Treatment Options in Infectious Diseases 2020; 12(3): 296 doi: 10.1007/s40506-020-00231-8
|
| 19 |
Jui-Hsiang Hung, Chiao-Feng Teng, Hsu-chin Hung, Yi-Lin Chen, Pin-Jun Chen, Chung-Liang Ho, Cheng-Hsiang Chuang, Wenya Huang. Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies. Annals of Hepatology 2024; 29(6): 101546 doi: 10.1016/j.aohep.2024.101546
|
| 20 |
P. Pateria, G. P. Jeffrey, G. MacQuillan, D. Speers, H. Ching, M. A. Chinnaratha, G. F. Watts, L. A. Adams. The association between chronic hepatitis C infection and cardiovascular risk. Internal Medicine Journal 2016; 46(1): 63 doi: 10.1111/imj.12936
|
| 21 |
Ting-ting Gao, Zhao-ling Qin, Hao Ren, Ping Zhao, Zhong-tian Qi. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0241-4
|
| 22 |
Q.‐t. Huang, Q. Huang, M. Zhong, S.‐s. Wei, W. Luo, F. Li, Y.‐h. Yu. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta‐analysis of observational studies. Journal of Viral Hepatitis 2015; 22(12): 1033 doi: 10.1111/jvh.12430
|
| 23 |
Antonio De Vincentis, Luisa Costanzo, Umberto Vespasiani-Gentilucci, Antonio Picardi, Stefania Bandinelli, Luigi Ferrucci, Raffaele Antonelli Incalzi, Claudio Pedone. Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people. Digestive and Liver Disease 2019; 51(9): 1330 doi: 10.1016/j.dld.2019.01.017
|
| 24 |
Sergio Salgüero, David Rojo, Juan Berenguer, Juan González‐García, Amanda Fernández‐Rodríguez, Oscar Brochado‐Kith, Cristina Díez, Victor Hontañon, Ana Virseda‐Berdices, Javier Martínez, Luis Ibañez‐Samaniego, Elba Llop‐Herrera, Coral Barbas, Salvador Resino, María A. Jiménez‐Sousa. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV‐coinfected and HCV‐monoinfected patients. Liver International 2020; 40(9): 2215 doi: 10.1111/liv.14580
|
| 25 |
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease association. Arab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
|
| 26 |
Adriano M. Pellicelli, Valeria Pace Palitti, Pascal Vignally, Francesca Ceccherini‐Silberstein, Massimo Siciliano, Valerio Giannelli, Alessandra Moretti, Pierluigi Tarquini, Gaetano Scifo, Vincenzo Messina, Antonio Ascione, Antonio Izzi, Massimo Marignani, Cecilia D'Ambrosio, Lucia Fondacaro, Giuseppe M. Ettorre, Pasquale Ialongo, Rodolfo Sacco, Carlo F. Perno, Giorgio Barbarini. Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real‐life study. Liver International 2017; 37(5): 653 doi: 10.1111/liv.13288
|
| 27 |
Theodoros Voulgaris, Vassilios A. Sevastianos. Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus. Hepatitis Research and Treatment 2016; 2016: 1 doi: 10.1155/2016/7629318
|
| 28 |
Ming-Ling Chang. Metabolic alterations and hepatitis C: From bench to bedside. World Journal of Gastroenterology 2016; 22(4): 1461-1476 doi: 10.3748/wjg.v22.i4.1461
|
| 29 |
Silvia Goñi Esarte, Regina Juanbeltz, José Manuel Zozaya, Juan Isidro Úriz, Jesús Castilla, José Ignacio Herrero. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents. Gastroenterología y Hepatología (English Edition) 2020; 43(5): 248 doi: 10.1016/j.gastre.2019.03.027
|
| 30 |
Madison Schank, Juan Zhao, Ling Wang, Lam Ngoc Thao Nguyen, Dechao Cao, Xindi Dang, Sushant Khanal, Jinyu Zhang, Yi Zhang, Xiao Y. Wu, Shunbin Ning, Mohamed El Gazzar, Jonathan P. Moorman, Zhi Q. Yao. Oxidative Stress Induces Mitochondrial Compromise in CD4 T Cells From Chronically HCV-Infected Individuals. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.760707
|
| 31 |
|